Status:

UNKNOWN

Anti-Aggregative Therapy and Laser Iridectomy

Lead Sponsor:

Sheba Medical Center

Conditions:

Eyes With Narrow Angle

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patien...

Eligibility Criteria

Inclusion

  • patients with narrow angle that need laser iridectomy and take anti- aggregative treatment
  • over 20 years old
  • patients who can stop their anti-aggregative treatment for 10 days

Exclusion

  • under coumadin treatment
  • post ocular surgeries

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00426400

Start Date

March 1 2006

Last Update

January 24 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Goldschleger Eye Institute

Tel Litwinsky, Israel

Anti-Aggregative Therapy and Laser Iridectomy | DecenTrialz